SCIENCE & TECHNOLOGY Such toxic effects are a result of acetaminophen bioactivation, in which liver enzymes transform the drug into problematic metabolites. One of these metabolic products is N-acetyl-j&-benzoquinone imine, which causes liver cells to die when the compound is produced in amounts too large to be neutralized. The Parke-Davis and Warner-Lambert antidiabetic drug troglitazone (Rezulin) was withdrawn from the market in 2000 after it, STU BORMAN, C&EN WASHINGTON too, was found to cause severe liver toxicity. with acetaminophen, troglitazone's toxIn thefirstplace, let us agree that the word poison does not exist, because in medicine use is made As ofthe icity most violentpoisons, which become, according as they are employed, most salutary remedies.—"THE has been attributed to a bioactivation mechanism, in which the drug's reactive COUNT OF MONTE CRISTO " ALEXANDRE DUMAS metabolites bind to cell proteins and the resulting complexes somehow damage cells TOXIC DRUG WAS A VALUABLE at the conference described some of these and organs. Senior investigator ByoungJoon asset to the Count of Monte tools and their efforts to improve and reSong at the National Institute on Alcohol Cristo. In the novel of that fine them. Abuse & Alcoholism, Rockville, Md., and name by Alexandre Dumas, the On average, scientists test about 10,000 coworkers suspect that this damage may count uses a potentially toxic compounds before they find one that can be occur by a new mechanism of drug toxicity medication in a revenge plot against a public marketed as a drug, said the other cochair, they discovered recently. prosecutor who had sentenced him unjustly F. Peter Guengerich, director of the Cen-
MINIMIZING DRUG TOXICITY
Conference spotlights advances in mechanistic studies and in methods to predict toxicity
A
to life in prison. But to the modern drug industry, toxic medications are not assets at all but instead major liabilities. Toxicity prevents many compounds from being developed and approved. And it occasionally forces withdrawal of an approved drug from the market, a recent notable example being Merck's withdrawal of the arthritis drug Vioxx in 2004 owing to cardiovascular side effects. The drug industry expends considerable time and effort trying to avoid or at least minimize such toxic effects. Its work includes deterrnining the mechanisms of toxic responses, developing ways to predict them as early as possible in the drug discovery process, and monitoring them carefully after drug approval. Such efforts were among the topics discussed at "Applying Mechanisms of Chemical Toxicity To Predict Drug Safety," an ACS ProSpectives conference held last month in Washington, D.C. THE FIELD of chemical toxicity has advanced considerably over the past quarter century, according to James S. MacDonald, executive vice president of preclinical development at Schering-Plough Research Institute, Kenilworth, NJ., who cochaired the conference. "Twenty-five years ago we were just beginning to understand the chemical basis of cellular toxicity," MacDonald said. Since then, researchers have developed a much sounder scientific basis for understanding chemically mediated toxic responses. Toxicologists currently use "very powerful tools to detect cellular signals of toxicity and better predict human risk from chemical exposure," MacDonald said. Researchers WWW.CEN-0NLINE.ORG
They found that certain toxic compounds, ter in Molecular Toxicology at Vanderbilt such as acetaminophen and the anticancer University School of Medicine, Nashville, agents staurosporine and in opening remarks at etoposide, or their reacthe conference. "Many 0 tive metabolites, actucompounds fall off the ally cause cell and organ drug discovery pipeline damage by activating at different steps along apoptosis-inducing prothe way, often because of tein kinases, such as ctoxicity. Human adverse Jun N-terminal protein effects and animal tox0H kinase (JNK) and p38 icity account for about
11
one-third of failures" in drug discovery and development. "So toxicity is one of the most serious barriers to drug development."
Acetaminophen 0
kinase (J. Biol. Chem., published online May 18, dx.doi.org/10.1074/jbc. M510644200). W h e n J N K and/or p38 kinase is activated, one or both phosphorylate a protein called Bax. This, in turn, activates Bax to move from the cytoplasm to mitochondria, where it induces apoptosis. Troglitazone may work this way as well, as it activates both J N K and p38 kinase, but Song's group has not yet confirmed the mechanism for troglitazone.
A common and wellknown mechanism of toxicity is bioactivation, 0 the metabolic transformation of drugs into reW-Acetyl-p-benzoquinone imine active agents capable of participating in mischieBIOACTIVATION A classic vous interactions and toxicity mechanism is the reactions. Such interacenzymatic breakdown of the tions often involve the analgesic acetaminophen formation of drug-proto form A/-acetyl-ptein adducts that can benzoquinone imine, which disrupt protein funcThe findings on the can cause liver damage. tion, cause cell and tissue toxic apoptotic mechadeath, and elicit immune reactions. nism "are new and explain the underlying mechanism for many previous reports about A classic example is the bioactivation the critical role of toxic drug- or metaboliteof acetaminophen, the active pain relief activated J N K and p38 kinase in cell and and fever-reducing agent in the Johnson & tissue damage," Song said. "In addition to acJohnson drug Tylenol and its many generic tivation of the apoptosis-signaling pathway, competitors. Acetaminophen side effects we also demonstrated that toxic compounds are rare. But the drug can cause liver damand reactive metabolites may promote celage and even liver failure, especially when lular damage by increasing oxidative and combined with alcohol. C & E N / JULY 3, 2006
37
BEST
PRACTICES
Use Best Practices to Manage Your Lab Chemical Inventory Leveraging Best Practices When Implementing a Chemical Inventory System Helps Ensure System Adoption and Successful Incorporation into Lab Processes Optimize Safety and Quality Chemical Data Management Companies that utilize chemicals in their labs and their manufacturing processes must manage those chemicals in a safe environment in accordance with government regulations. At a minimum, to ensure that this is accomplished, a system for managing information about the chemical safety and quality data should be established and maintained. Best practices, on the other hand, take this minimum and leverage the management of the chemical inventory by leveraging the abilities of the people, processes, and technology involved to best effect
Inventory Systems Support Best Practices If you need to better manage your chemical inventory, then a Chemical Inventory System (CIS) program can help enable your organization to perform effective chemical stock monitoring, forecasting, and setting and assessing chemical stock levels, thus reducing stock levels, costs, liability, and environmental impact. A best practices CIS enables labs to not only track chemical location and use, but also generate reports and quickly access hazard information.
White Paper Identifies Critical System Components To help ensure that you know all the components of an effective CIS and how to make it work for you, get a copy of ChemSW's white paper entitled Best Practices for Managing Chemical Inventory, which details best practices in chemical inventory management and provides insights to ensure system adoption and successful incorporation into lab processes. Reasons why systems fail and why they succeed are examined, as well as the true costs associated with chemical inventory management and cost savings that result when such a system is optimized for maximum effectiveness. For your free copy of this white paper, visit www.ChemSW.com/BestPracticeCEN.htm today or call (707) 864-0845. • • U j 1
nitrosative stress, which eventually causes mitochondrial dysfunction." To avoid toxicity problems, most drug companies try to ensure that drug candidates aren't likely to form problematic metabolites. They often do this "by making structural modifications that would tend to prevent the formation of reactive species," said David C. Evans, vice president ofglobal preclinical development atJ&J Pharmaceutical R&D, Raritan, N J. Companies particularly try to steer clear of compounds bearing functional groups that are known troublemakers. According to Sidney D. Nelson, professor of medicinal chemistry and dean of the School of Pharmacy at the University of Washington, Seattle, groups that are best avoided when possible include hydrazines and hydrazides; arylacetic or arylpropionic acids; thiophenes, furans, or pyrroles; anilines and anilides; quinones and quinone imines; and nitroaromatics. Other key factors that determine the likelihood of drug toxicity, Nelson said, include the relative rates at which toxic metabolites are formed and destroyed, the tendency of biomolecular adducts of drugs and metabolites to induce immune reactions, the efficiency with which cells are able to repair problems caused by toxic mechanisms, and the required dosage level of a drug. The drug the Count of Monte Cristo used saved lives at moderate doses but took them at higher ones. Sometimes it's possible to redesign a drug that's been found to be toxic. Timothy L. Macdonald, professor of chemistry at the University of Virginia, Charlottesville, and coworkers recently redesigned felbamate, a drug that exhibits idiosyncratic toxicity, an unpredictable toxic drug reaction of unknown cause. Idiosyncratic toxicity is a major cause of withdrawal and restriction of marketed drugs. Felbamate is an antiepileptic approved in 1993. It was then the first new antiepileptic drug approved in more than a decade and was shown to be useful to patients who had not responded well to other antiepileptics. But within a year, it was found to damage the liver and cause idiosyncratic aplastic anemia, a condition in which the bone marrow produces insufficient amounts of blood-forming stem cells. In 1994, the Food & Drug Administration therefore restricted the drug to compassionate use, available only to patients with no alternative. Felbamate currently has two black box warnings, one for potentially fatal aplastic anemia and one for acute liver failure. A black box warning, the strongest type of
JNK p38 kinase Certain toxic compounds and reactive metabolites
Activated JNK Activated p38 kinase
Activated phospho-Bax
Mitochondrion Apoptosis P = phosphate
APOPTOSIS MECHANISM Song and coworkers recently found that certain toxic compounds cause apoptosis by activating c-Jun N-terminal protein kinase (JNK) and/or p38 kinase. When activated, these enzymes phosphorylate and thus activate Bax protein to refold and translocate from the cytoplasm to mitochondria, where it induces apoptosis. Green and red rectangles are protein domains that interact in unactivated Bax but no longer associate in activated phosphorylated Bax. notice FDA can require for a marketed drug, alerts prescribers and patients about adverse drug reactions that can cause serious injury or death. THE MECHANISM of toxicity is believed to be an immune reaction to a protein conjugate of the felbamate metabolite 2-phenylpropenal. Macdonald and coworkers used a mechanism-based design strategy to develop an analog,fluorofelbamate,that cannot form that type of conjugate. Fluorofelbamate is five times more potent than felbamate and so far has exhibited no toxicity, demonstrating the important role chemistry can play in addressing drug toxicity issues. The analog is currently in clinical trials. Researchers continue to develop a range of advanced techniques to better evaluate toxic mechanisms and predict drug toxicity. "What we'd really like are more assays that make intelligent predictions of toxicity from the biology," Guengerich said. One such tool is toxicogenomics, in which studies are carried out on changes in gene expression that occur in response
Request more at AdlnfoNow.org 38
C & E N / JULY 3, 2006
WWW.CEN-0NLINE.ORG
Your global search ends here...! to administration of a drug. The goal of toxicogenomics is to identify mechanisms of action of toxicants and develop biomarkers (biomolecular indicators) that can be used to detect toxic processes. At the meeting, research fellow Lois Lehman-McKeeman of Bristol-Myers Squibb, Princeton, NJ., described a recent study by a Japanese group in which toxicogenomics was used to study the mechanism by which some drugs cause phospholipidosis, a lipid storage disorder. The group used DNA microarrays to analyze gene expression changes in human cells treated with compounds known to induce phospholipidosis. The researchers found that in cells so exposed, changes occur in the metabolism of cholesterol and in the function of rysosomes, organelles in which compounds are broken down to simpler substances. They identified biomarkers of phospholipidosis—gene expression patterns that indicate the condition is being activated—and developed a rapid and sensitive screening test for druginduced phospholipidosis based on those biomarkers. Toxicogenomics can also be carried out by analyzing changes in mRNA transcripts of expressed genes (transcriptomics) or in
the proteins so expressed (proteomics). The challenge of toxicogenomics is that so many complex changes occur in gene expression, mRNA transcripts, or protein production in response to drug administration that the direct effects of the drug are difficult to isolate, analyze, and understand. Another developing technique for toxicological studies is metabonomics. In metabonomics, nuclear magnetic resonance and mass spectrometry of body fluids and tissues, combined with pattern recognition, are used to establish toxic mechanisms of action and identify biomarkers of toxicity. "The breadth and depth of preclinical metabonomics applications have been increasing dramatically/' said Donald G. Robertson, director and research fellow of Pfizer Global R&D, Ann Arbor, Mich. The technique "is expanding the perspective of how we evaluate the safety of novel compounds."
THE UPSIDE of metabonomics is that it makes it possible to understand experimental toxicology models and their limitations "to a much greater extent than we have in the past, and it makes us aware of offtarget effects that maybe completely missed by traditional analyses," Robertson said. But as with toxicogenomics, transcriptomics, and proteomics, he added, "the downside is that the NH9 perspective is so comprehensive that Felbamate the data can be quite difficult to deconvolve into testable mechanistic hypotheses." Despite these challenges, or maybe as a result of them, "this is an ex2-Phenylpropenal citing time in thefield"of chemical toxicity, said Guengerich. "When I first began my career, human metabolism was a vast unknown in drug development. We now have a much better grip on that science, and preFluorofelbamate dictive toxicology is the new frontier in developing safe new drugs. "We certainly are not there yet in terms ofwhat we would like to do," he DRUG REDESIGN Macdonald and said, "but scientific advances by both coworkers recently redesigned the industrial and academic participants antiepileptic drug felbamate, a toxic are providing new approaches. Aldrug that can cause aplastic anemia and though predictive toxicology is not at acute liver failure. The toxicity is believed the point where we have a simple and to be an immune reaction to a protein cheap general screen—and we may conjugate of the felbamate metabolite never have one—the methods are now 2-phenylpropenal. The redesigned agent, already being used quite effectively in fluorofelbamate, cannot form this kind reaching key decisions, not only about of conjugate. It is five times more potent choices of candidates within a group than felbamate, has exhibited no toxicity, but about the validity of attacking cerand is currently in clinical trials. tain drug targets. I see a lot happening in the next few years." •
A vibrant vendor base spread across India, we can bring enormous sourcing opportunities for speciality fine chemicals as well as getting them custom manufactured. Our Specialities are: •:• Unique open and transparent policy enabling moral binding with custom manufacturing. •
Sourcing based N O T upon chemical directories but upon CHEMISTRY, which in turn is well-supported by a panel of experts & hence globally competitive prices as a result of combination of right choice chemistry a n d established commercial acumen
v A number of satisfied and loyal overseas customersin Germany, Switzerland,USA, Japan, China and Taiwan * A large pool of vendors capable of custom manufacturing at short notice and working up different kinds of chemistry including hydrogenation, cyanation.ethynylation, butyl lithium and acetylenic chemistry. Item
CasNo
5-Acetylthiophene-2-carboxylic acid Alcian Blue 8GX 5-Azaindole 7-Azaindole Bredereck's Reagent Bromocresol Green 3-Bromofuran Cyclam Dess Martin Periodane 1,3-Diallylurea 1,8-Dibromooctane 1 -[3-dimethylaminopropyl] -3-ethylcarbodiimide hydrochloride [N-ethyl-N'-[3-dimethylaminopropyl] Carbodiimide HCI, EDC-HCI, WSC-HCI] 1,3-Dimethyl-2-imidazolidinone 2,5-Diphenyloxazole [PPO] FlavianicAcid Furan-2,5-Dicarboxylic acid 3-Furfuraldehyde 3-Furoic acid Hexamethyldisilane 1-Hexyl-2,3-dimethylimidazolinium chloride 4-Hydroxybenzhydrazide Methanesulfinic acid sodium salt 4-Methylquinoline Nile Red 4-Nitroindole N-octylpyridinium chloride 1,8-Octanediol Pyrrole-2-carboxaldehyde 1-H-pyrrole-2-carboxylic acid 2,4,6-Trimethylphenol 2,4,6-Triisopropylacetophenone 2,4,6-Triisopropylbenzenesulfonyl chloride 1-[2,4,6-Triisopropylbenzenesulphonyl] -imidazole Trimethylsilyl cyanide Trimethylsilyl triflate
4066-41-5 33864-99-2 271-34-1 271-63-6 5815-08-7 76-60-J 22037-28-1 295-37-4 87413-09-0 1801-72-5 4549-32-0 25952-53-8
80-73-9 92-71-7 483-84-1 3238-40-2 498-60-2 488-93-7 1450-14-2 455270-59-4 5351-23-5 20277-69-4 491-35-0 7385-67-3 4769-97-5 4086-73-1 629-414 1003-29-8 634-97-9 527-60-6 2234-14-2 655-96-4 50257-40-4 7677-24-9 27607-77-8
Resource Research International
Itlti; mmiMMsum 62, Wadia Building, 3rd Floor, 9B, Cawasji Patel Street, Fort, MUMBAI 400 001, INDIA Tel.: +91-22-6636 9451/52 Fax: +91-22-6636 9454 Email:
[email protected] Please ask for our exclusive list of more than 2000 readily sourceable fine chemicals Request more at AdlnfoNow.org
WWW.CEN-0NLINE.ORG
C & E N / JULY 3, 2006
39
